Most people experience some level of cognitive decline as they get older. It’s a cruel, albeit normal part of the ageing process. Losing agency, cognition and function to Alzheimer’s disease is far from normal, and affects 1 in 10 Australians over 65 years of age, and 1 in 3 over 85. Whilst pharmacologics do exist
Read More
Estimated to affect 1 in every 4,000 boys, there is currently no treatment approved in the world for cognitive disorder Fragile X Syndrome but that could change in the coming years with biotech company Actinogen (ASX: ACW) confirming a manager to oversee the Phase 2 trials of its XanaFX clinical trials. Fragile X Syndrome is
Read More
Our minds can be our greatest asset and our biggest enemy. The same humans that built aeroplanes, rockets and the internet are just as prone to ailments like depression, anxiety and functional cognitive decline. Unfortunately when it comes to cognition, doing the odd sudoku probably won’t cut it if you’re hoping to maintain your current
Read More